BioMarin Pharmaceutical | BMRN - Trade Debtors



BioMarin Pharmaceutical reported $855.85M in Trade Debtors for its fiscal quarter ending in June of 2025.


Trade Debtors Change Date
Acadia Pharmaceuticals USD 119.69M 5.97M Jun/2025
Agios Pharmaceuticals USD 4.99M 1.64M Jun/2025
Alnylam Pharmaceuticals USD 567.11M 149.08M Jun/2025
Amgen USD 8.7B 569M Jun/2025
Bayer EUR 17.64B 895M Jun/2025
Biogen USD 2.08B 87.5M Jun/2025
BioMarin Pharmaceutical USD 855.85M 116.68M Jun/2025
Gilead Sciences USD 4.78B 393M Jun/2025
Incyte USD 842.89M 19.76M Jun/2025
Insmed USD 55.03M 7.29M Jun/2025
Ionis Pharmaceuticals USD 52.58M 12.87M Jun/2025
Moderna USD 457M 151M Jun/2025
Neurocrine Biosciences USD 595.7M 79.7M Jun/2025
PTC Therapeutics USD 196.13M 14.36M Jun/2025
Regeneron Pharmaceuticals USD 5.61B 49M Jun/2025
Roche Holding CHF 13.46B 984M Dec/2024
Sanofi 8.21B 2.42B Jun/2025
Sarepta Therapeutics USD 609.6M 114.93M Jun/2025
Ultragenyx Pharmaceutical USD 124.46M 25.62M Jun/2025
United Therapeutics USD 379.3M 57.3M Jun/2025
Vertex Pharmaceuticals USD 1.89B 88.4M Jun/2025